Exploring the Impact of de Novo Everolimus on Key Determinants of Long Term Outcome After Kidney Transplantation: NODAT, Viral Infection, DSA, Proteinuria and Graft Histology
Phase of Trial: Phase IV
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Everolimus (Primary) ; Ciclosporin; Mycophenolic acid; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms ADVISE
- Sponsors Novartis
- 14 Nov 2017 Planned End Date changed from 1 Dec 2017 to 31 Dec 2017.
- 14 Nov 2017 Planned primary completion date changed from 1 Dec 2017 to 31 Dec 2017.
- 06 Jan 2016 According to ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.